Tenatoprazole

Research use only, not for human use.

Tenatoprazole, a prodrug of the proton pump inhibitor (PPI) class, can inhibit proton transport (IC50: 3.2 μM).

Tenatoprazole, also known as TU-199, is a proton pump inhibitor drug candidate that was undergoing clinical testing as a potential treatment for reflux oesophagitis and peptic ulcer. Tenatoprazole has an imidazopyridine ring in place of the benzimidazole moiety found in other proton pump inhibitors, and has a half-life about seven times longer than other PPIs.

——

——

TU-199 | Tenatoprazole | Ulsacare | Protop

Others

Other Targets

Proton pump

Inflammation/Immunology

——

113712-98-4

346.4

C16H18N4O3S

>98% (HPLC)

In Vitro:?DMSO : 50 mg/mL (144.34 mM)

COc1ccc2[nH]c(nc2n1)S(=O)Cc1c(C)c(OC)c(C)cn1

5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-imidazo[4,5-b]pyridine

(-20℃)

With Ice Pack

≥ 2 years